04/09/2025
This interesting webinar will be online on Thursday, October 9, 2025 at 1:00 PM CET
PRESENTER:
Sara Gianella Weibel, MD
University of California San Diego
MODERATOR:
Kristine M. Erlandson, MD, MS
University of Colorado School of Medicine, Aurora, CO
This webinar will present new data from the A5383 (Randomized, Controlled Trial to Evaluate the Anti-inflammatory Efficacy of Letermovir [Prevymis] in Adults With HIV-1 and Asymptomatic Cytomegalovirus [CMV] Who Are on Suppressive Antiretroviral Therapy and Its Effect on Chronic Inflammation, HIV Persistence, and Other Clinical Outcomes [ELICIT]) trial on letermovir therapy and its effects on immune activation, CD4+ cell recovery, and functional aging in people with HIV. Attendees will gain insights into how targeting CMV may provide a novel avenue to improve long term health outcomes in populations undergoing HIV treatment.
Link for the access to the webinar:
https://www.iasusa.org/events/webinar-2025-gianella-weibel/